Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Apr-24 5:33 PM View:  | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 09-Apr-24 | Planned Option Sale | 857 | $92.34 | $79,135.40 | (5%) 18.34K to 17.49K | |
| 09-Apr-24 5:33 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 09-Apr-24 | Option Exercise | 857 | $36.75 | $31,494.80 | 5% 17.49K to 18.34K | |
| 08-Apr-24 5:10 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 08-Apr-24 | Planned Option Sale | 12,500 | $92.33 | $1,154,140.00 | (6%) 225.97K to 213.47K | |
| 08-Apr-24 5:10 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 08-Apr-24 | Option Exercise | 12,500 | $36.75 | $459,375.00 | 6% 213.47K to 225.97K | |
| 08-Apr-24 5:10 PM View: | Lemercier Jean-Luc M CVP, EMEACLA | Edwards Lifesciences Corp. (EW) | 08-Apr-24 | Option Exercise | 14,400 | $36.75 | $529,200.00 | 8% 173.85K to 188.25K | |
| 08-Apr-24 5:10 PM View: | Lemercier Jean-Luc M CVP, EMEACLA | Edwards Lifesciences Corp. (EW) | 08-Apr-24 | Planned Option Sale | 14,400 | $92.32 | $1,329,470.00 | (8%) 188.25K to 173.85K | |
| 04-Apr-24 6:26 PM View: | Mussallem Michael A Director | Edwards Lifesciences Corp. (EW) | 04-Apr-24 | Planned Option Sale | 29,350 | $92.42 | $2,712,420.00 | (< 1%) 4.07M to 4.04M | |
| 04-Apr-24 6:26 PM View: | Mussallem Michael A Director | Edwards Lifesciences Corp. (EW) | 04-Apr-24 | Option Exercise | 29,350 | $36.75 | $1,078,610.00 | < 1% 4.04M to 4.07M | |
| 01-Apr-24 6:55 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 01-Apr-24 | Planned Option Sale | 7,255 | $94.89 | $688,423.00 | (2%) 292.65K to 285.39K | |
| 01-Apr-24 6:55 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 01-Apr-24 | Option Exercise | 7,255 | $36.75 | $266,621.00 | 3% 285.39K to 292.65K | |
| 13-Mar-24 5:44 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 13-Mar-24 | Option Exercise | 14,500 | $36.75 | $532,875.00 | 7% 213.2K to 227.7K | |
| 13-Mar-24 5:44 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 13-Mar-24 | Planned Option Sale | 14,500 | $91.01 | $1,319,700.00 | (6%) 227.7K to 213.2K | |
| 11-Mar-24 6:00 PM View: | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Edwards Lifesciences Corp. (EW) | 11-Mar-24 | Option Exercise | 14,400 | $36.75 | $529,200.00 | 8% 173.58K to 187.98K | |
| 11-Mar-24 6:00 PM View: | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Edwards Lifesciences Corp. (EW) | 11-Mar-24 | Planned Option Sale | 14,400 | $91.68 | $1,320,150.00 | (8%) 187.98K to 173.58K | |
| 07-Mar-24 6:22 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 07-Mar-24 | Option Exercise | 1,715 | $36.75 | $63,026.20 | 10% 17.21K to 18.93K | |
| 07-Mar-24 6:22 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 07-Mar-24 | Planned Option Sale | 1,715 | $90.98 | $156,031.00 | (9%) 18.93K to 17.21K | |
| 04-Mar-24 7:16 PM View: | Mussallem Michael A Director | Edwards Lifesciences Corp. (EW) | 04-Mar-24 | Planned Option Sale | 29,350 | $86.67 | $2,543,740.00 | (< 1%) 4.07M to 4.04M | |
| 04-Mar-24 7:16 PM View: | Mussallem Michael A Director | Edwards Lifesciences Corp. (EW) | 04-Mar-24 | Option Exercise | 29,350 | $36.75 | $1,078,610.00 | < 1% 4.04M to 4.07M | |
| 29-Feb-24 5:12 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 29-Feb-24 | Planned Option Sale | 7,255 | $85.59 | $620,923.00 | (2%) 292.65K to 285.39K | |
| 29-Feb-24 5:12 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 29-Feb-24 | Option Exercise | 7,255 | $36.75 | $266,621.00 | 3% 285.39K to 292.65K | |
| 26-Feb-24 5:52 PM View: | Gallahue Kieran Director | Edwards Lifesciences Corp. (EW) | 23-Feb-24 | Gift | 7,056 | -- | -- | (9%) 81.03K to 73.98K | |
| 26-Feb-24 5:52 PM View: | Gallahue Kieran Director | Edwards Lifesciences Corp. (EW) | 23-Feb-24 | Option Exercise | 7,056 | $36.86 | $260,107.00 | 10% 73.98K to 81.03K | |
| 26-Feb-24 5:52 PM View: | Gallahue Kieran Director | Edwards Lifesciences Corp. (EW) | 23-Feb-24 | Gift | 7,056 | -- | -- | 11% 66.92K to 73.98K | |
| 26-Feb-24 5:52 PM View: | Gallahue Kieran Director | Edwards Lifesciences Corp. (EW) | 23-Feb-24 | Option Sale | 3,058 | $87.61 | $267,911.00 | (4%) 73.98K to 70.92K | |
| 23-Feb-24 6:51 PM View: | Sellers Robert W.A. SVP, Corporate Controller | Edwards Lifesciences Corp. (EW) | 22-Feb-24 | Grant | 1,998 | -- | -- | 6% 33.5K to 35.49K | |
| 23-Feb-24 6:51 PM View: | Szyman Catherine M CVP, Critical Care | Edwards Lifesciences Corp. (EW) | 22-Feb-24 | Grant | 8,560 | -- | -- | 25% 34.81K to 43.37K | |
| 21-Feb-24 5:52 PM View: | Chopra Daveen CVP, TMTT | Edwards Lifesciences Corp. (EW) | 21-Feb-24 | Sale | 1,200 | $86.74 | $104,089.00 | (5%) 23.95K to 22.75K | |
| 21-Feb-24 5:52 PM View: | Chopra Daveen CVP, TMTT | Edwards Lifesciences Corp. (EW) | 21-Feb-24 | Option Exercise | 7,000 | $59.26 | $414,797.00 | 29% 23.95K to 30.95K | |
| 21-Feb-24 5:52 PM View: | Chopra Daveen CVP, TMTT | Edwards Lifesciences Corp. (EW) | 21-Feb-24 | Option Sale | 7,000 | $86.74 | $607,183.00 | (23%) 30.95K to 23.95K | |
| 20-Feb-24 5:49 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 18-Feb-24 | Payment of Exercise | 188 | $86.10 | $16,186.80 | (1%) 17.4K to 17.21K | |
| 20-Feb-24 5:49 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 17-Feb-24 | Payment of Exercise | 150 | $86.10 | $12,915.00 | (< 1%) 17.55K to 17.4K | |
| 16-Feb-24 6:40 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 16-Feb-24 | Payment of Exercise | 174 | $86.04 | $14,971.00 | (< 1%) 285.57K to 285.39K | |
| 20-Feb-24 5:49 PM View: | Lippis Daniel J. CVP, JAPAC | Edwards Lifesciences Corp. (EW) | 16-Feb-24 | Payment of Exercise | 207 | $86.04 | $17,810.30 | (1%) 17.76K to 17.55K | |
| 16-Feb-24 6:39 PM View: | Wood Larry L Global President TAVR & Surg | Edwards Lifesciences Corp. (EW) | 16-Feb-24 | Payment of Exercise | 317 | $86.04 | $27,274.70 | (< 1%) 214.29K to 213.97K | |
| 15-Feb-24 5:25 PM View: | Szyman Catherine M CVP, Critical Care | Edwards Lifesciences Corp. (EW) | 15-Feb-24 | Option Exercise | 27,000 | $36.75 | $992,250.00 | 78% 34.81K to 61.81K | |
| 15-Feb-24 5:25 PM View: | Szyman Catherine M CVP, Critical Care | Edwards Lifesciences Corp. (EW) | 15-Feb-24 | Option Sale | 27,000 | $85.62 | $2,311,650.00 | (44%) 61.81K to 34.81K | |
| 13-Feb-24 4:51 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 13-Feb-24 | Option Exercise | 11,000 | $36.75 | $404,250.00 | 5% 213.16K to 224.16K | |
| 15-Feb-24 5:25 PM View: | Szyman Catherine M CVP, Critical Care | Edwards Lifesciences Corp. (EW) | 13-Feb-24 | Option Sale | 20,000 | $86.46 | $1,729,200.00 | (36%) 54.81K to 34.81K | |
| 13-Feb-24 4:51 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 13-Feb-24 | Planned Option Sale | 11,000 | $85.83 | $944,155.00 | (5%) 224.16K to 213.16K | |
| 15-Feb-24 5:25 PM View: | Szyman Catherine M CVP, Critical Care | Edwards Lifesciences Corp. (EW) | 13-Feb-24 | Option Exercise | 20,000 | $36.75 | $735,000.00 | 57% 34.81K to 54.81K | |
| 12-Feb-24 5:44 PM View: | Sellers Robert W.A. SVP, Corporate Controller | Edwards Lifesciences Corp. (EW) | 12-Feb-24 | Option Exercise | 12,210 | $36.75 | $448,718.00 | 36% 33.5K to 45.71K | |
| 12-Feb-24 5:44 PM View: | Sellers Robert W.A. SVP, Corporate Controller | Edwards Lifesciences Corp. (EW) | 12-Feb-24 | Option Sale | 12,210 | $87.00 | $1,062,270.00 | (27%) 45.71K to 33.5K | |
| 08-Feb-24 6:08 PM View: | Stone Heisz Leslie Director | Edwards Lifesciences Corp. (EW) | 08-Feb-24 | Option Exercise | 7,056 | $36.86 | $260,107.00 | 26% 26.98K to 34.04K | |
| 08-Feb-24 6:08 PM View: | Stone Heisz Leslie Director | Edwards Lifesciences Corp. (EW) | 08-Feb-24 | Option Sale | 7,056 | $86.45 | $609,991.00 | (21%) 34.04K to 26.98K | |
| 05-Feb-24 6:37 PM View: | Mussallem Michael A Director | Edwards Lifesciences Corp. (EW) | 05-Feb-24 | Planned Option Sale | 29,350 | $87.49 | $2,567,750.00 | (< 1%) 4.07M to 4.04M | |
| 05-Feb-24 6:37 PM View: | Mussallem Michael A Director | Edwards Lifesciences Corp. (EW) | 05-Feb-24 | Option Exercise | 29,350 | $36.75 | $1,078,610.00 | < 1% 4.04M to 4.07M | |
| 01-Feb-24 5:52 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 01-Feb-24 | Planned Option Sale | 7,255 | $78.29 | $567,994.00 | (2%) 292.82K to 285.57K | |
| 01-Feb-24 5:52 PM View: | Ullem Scott B. CVP, Chief Financial Officer | Edwards Lifesciences Corp. (EW) | 01-Feb-24 | Option Exercise | 7,255 | $36.75 | $266,621.00 | 3% 285.57K to 292.82K | |
| 12-Jan-24 5:36 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 12-Jan-24 | Planned Option Sale | 10,000 | $75.67 | $756,700.00 | (4%) 223.1K to 213.1K | |
| 12-Jan-24 5:36 PM View: | Bobo Donald E Jr CVP,Strategy/Corp Development | Edwards Lifesciences Corp. (EW) | 12-Jan-24 | Option Exercise | 10,000 | $36.75 | $367,500.00 | 5% 213.1K to 223.1K |
